Si-Bone Inc (NASDAQ:SIBN) — Market Cap & Net Worth
Market Cap & Net Worth: Si-Bone Inc (SIBN)
Si-Bone Inc (NASDAQ:SIBN) has a market capitalization of $513.67 Million ($513.67 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #11893 globally and #3003 in its home market, demonstrating a 7.83% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Si-Bone Inc's stock price $17.76 by its total outstanding shares 44243715 (44.24 Million). See Si-Bone Inc capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Si-Bone Inc Market Cap History: 2018 to 2026
Si-Bone Inc's market capitalization history from 2018 to 2026. Data shows change from $924.25 Million to $785.77 Million (-1.55% CAGR).
Index Memberships
Si-Bone Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.02% | #326 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #1184 of 3165 |
Weight: Si-Bone Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Si-Bone Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Si-Bone Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.34x
Si-Bone Inc's market cap is 4.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $924.25 Million | $55.38 Million | -$17.45 Million | 16.69x | N/A |
| 2019 | $951.24 Million | $67.30 Million | -$38.40 Million | 14.13x | N/A |
| 2020 | $1.32 Billion | $73.39 Million | -$43.70 Million | 18.03x | N/A |
| 2021 | $982.65 Million | $90.15 Million | -$56.57 Million | 10.90x | N/A |
| 2022 | $601.71 Million | $106.41 Million | -$61.26 Million | 5.65x | N/A |
| 2023 | $928.68 Million | $138.89 Million | -$43.34 Million | 6.69x | N/A |
| 2024 | $620.30 Million | $167.18 Million | -$30.91 Million | 3.71x | N/A |
| 2025 | $872.49 Million | $200.93 Million | -$18.91 Million | 4.34x | N/A |
Competitor Companies of SIBN by Market Capitalization
Companies near Si-Bone Inc in the global market cap rankings as of August 3, 2026.
Key companies related to Si-Bone Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Si-Bone Inc Historical Marketcap From 2018 to 2026
Between 2018 and today, Si-Bone Inc's market cap moved from $924.25 Million to $ 785.77 Million, with a yearly change of -1.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $785.77 Million | -9.94% |
| 2025 | $872.49 Million | +40.66% |
| 2024 | $620.30 Million | -33.21% |
| 2023 | $928.68 Million | +54.34% |
| 2022 | $601.71 Million | -38.77% |
| 2021 | $982.65 Million | -25.72% |
| 2020 | $1.32 Billion | +39.07% |
| 2019 | $951.24 Million | +2.92% |
| 2018 | $924.25 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of Si-Bone Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $513.67 Million USD |
| MoneyControl | $513.67 Million USD |
| MarketWatch | $513.67 Million USD |
| marketcap.company | $513.67 Million USD |
| Reuters | $513.67 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Si-Bone Inc
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium … Read more